Neoadjuvant Chemoimmunotherapy or Chemoradiotherapy in ESCC
NCT07385664
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Resectable Esophageal Cancer
Interventions
COMBINATION_PRODUCT:
Neoadjuvant Chemoimmunotherapy or Concurrent Chemoradiotherapy
Sponsor
Ji Yongling